Huntington National Bank’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Huntington National Bank’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-653	Closed	-$10.3K	–	4170
2024 Q1	$10.3K	Buy	653 +46	+8%	+$708	﹤0.01%	1670
2023 Q4	$9.79K	Sell	607 -10	-2%	-$128	﹤0.01%	1659
2023 Q3	$7.85K	Buy	617 +162	+36%	+$2.23K	﹤0.01%	1654
2023 Q2	$6.41K	Buy	+455	New	+$6.51K	﹤0.01%	1717

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Huntington National Bank's DCPH Position: Q2 2024 in Review

Huntington National Bank sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 653 shares — an estimated $10.3K sold.

Huntington National Bank first reported a position in DCPH in Q2 2023 and held it in 4 quarters. The position peaked at $10.3K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Huntington National Bank reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Huntington National Bank sold 653 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $10.3K.
Huntington National Bank first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
Huntington National Bank's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $10.3K in Q1 2024.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Huntington National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.